![]() |
市场调查报告书
商品编码
1625428
鸦片类药物市场、规模、占有率、趋势、行业分析报告(按类别、产品、发布类型、应用和地区)- 市场预测,2025-2034 年Opioid Market Size, Share, Trends, Industry Analysis Report: By Class, Product, Release Type, Application, and Region - Market Forecast, 2025-2034 |
根据 Polaris Market Research 的一项新研究,全球鸦片类药物市场预计到 2034 年将达到 284.5 亿美元。该报告提供了有关当前市场动态的详细见解,并对未来市场的成长进行了分析。
鸦片类药物市场的成长得益于公司之间合作关係的增加。製药公司、医疗保健提供者和研究机构之间的合作正在促进鸦片类药物治疗新配方和改进输送系统的开发。这些联盟使公司能够整合资源、利用专业知识并加快研发进程,有助于更快地将有效的疼痛管理解决方案推向市场。此外,策略合作伙伴关係将改善分销网络并扩大鸦片类药物的获取管道,特别是在服务不足的地区。携手应对与鸦片类药物处方相关的课题,包括安全问题和法规遵从性,将促进更全面的疼痛管理方法,并最终减少鸦片类药物在市场上的占有率。
由于需要有效的疼痛管理,创伤性损伤的发生率不断上升是鸦片类药物市场需求的主要驱动力。美国每年报告约 150 万例创伤性脑损伤病例,其中许多需要住院和长期疼痛管理。疾病预防控制中心强调,在这些情况下,疼痛管理对于康復至关重要,这增加了对鸦片类药物的需求。此外,人们对创伤性脑损伤的长期影响的认识不断提高,凸显了全面疼痛策略的必要性,预计这将促使鸦片类药物处方进一步增加。因此,预计未来几年鸦片类药物市场规模将会扩大。
由于人们对疼痛管理的认识和教育不断提高,鸦片类药物市场正在扩大。患者和医疗保健提供者都越来越意识到可以选择的各种治疗方案。美国约有 5000 万成年人患有慢性疼痛。更新的医疗指南使医生在开立鸦片类药物时更有信心,并确保它们被适当地用于疼痛管理。人们对疼痛治疗方案的瞭解不断加深,促进了鸦片类药物在慢性疼痛管理中使用的增加。
根据释放类型,预计在预测期内,全球市场上延长/长效鸦片类药物部分将以显着的复合年增长率增长。这种增长是由于需要长效鸦片类药物治疗的长期疼痛和损伤的盛行率不断上升所推动的。
根据应用,由于慢性和急性损伤的增加,疼痛管理领域预计将在 2024 年占据市场最大的收入占有率。
由于医院数量的增加促使处方率上升,北美将在 2024 年占据全球鸦片类药物市场的主导占有率。
由于资本筹集和外国直接投资流入的增加,印度鸦片类药物市场预计将大幅成长。
全球市场的主要参与者包括 Aurobindo Pharma Limited;Assertio Therapeutics, Inc.;AbbVie Inc.;Actavis Plc.;Amneal Pharmaceuticals LLC;Boehringer Ingelheim International GmbH;Cadila Healthcare Limited;Fresenius Kabi;Mallinckrodt Pharmaceutical International GmbH;Cadila Healthcare Limited;Fresenius Kabilcuticals's Pharmaceuticals;Endolcuticals;Endolcuticals plcuticals; ;强生公司;Lupin Limited;Nesher Pharmaceuticals LLC;普渡製药有限公司;辉瑞公司;Rhodes Pharmaceuticals L.P.;太阳製药工业有限公司;Trevena Inc.;和Teva Pharmaceutical Industries Ltd.
The global opioid market size is expected to reach USD 28.45 billion by 2034, according to a new study by Polaris Market Research. The report "Opioid Market Size, Share, Trends, Industry Analysis Report: By Class, Product, Release Type (Immediate-Release/Short-Acting Opioid and Extended-Release/Long-Acting Opioid), Application, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The opioid market growth is attributed to an increase in partnerships between companies. Collaborations between pharmaceutical firms, healthcare providers, and research institutions are facilitating the development of new formulations and improved delivery systems for opioid therapies. These alliances enable organizations to combine resources, leverage expertise, and expedite the research and development process, allowing for faster introduction of effective pain management solutions to the market. Additionally, strategic partnerships improve distribution networks and expand access to opioid medications, particularly in underserved areas. Companies join forces to address challenges related to opioid prescribing such as safety concerns and regulatory compliance; they are promoting a more holistic approach to pain management, ultimately strengthening the presence of opioids in the market.
The rising prevalence of traumatic injuries significantly drives opioid market demand due to the need for effective pain management. The US reports around 1.5 million traumatic brain injury cases annually, with many requiring hospitalization and long-term pain management. The CDC highlights that pain management is essential for recovery in these cases, increasing the demand for opioids. Additionally, heightened awareness of the long-term effects of TBIs emphasizes the necessity for comprehensive pain strategies, further leading to an expected rise in opioid prescriptions. Consequently, the opioid market size is poised for growth in the projected years.
The opioid market is expanding due to increased awareness and education about pain management. Both patients and healthcare providers are learning more about the different treatment options available. In the United States, nearly 50 million adults suffer from chronic pain. Updated medical guidelines are helping doctors feel more confident when prescribing opioids, ensuring they are used properly to manage pain. This growing understanding of pain treatment options is contributing to the rise in the use of opioids for managing chronic pain.
By release type, the extended-release/long-acting opioid segment is anticipated to experience substantial growth at a significant CAGR in the global market during the forecast period. This growth is attributed to an increase in the prevalence of extended pain and traumatic injuries requiring long-acting opioids.
The pain management segment, by application, accounted for the largest revenue share of the market in 2024 due to the rising number of chronic and acute injuries.
In 2024, North America dominated the global opioid market share due to the increasing number hospitals, leading to the increase in prescription rate.
The opioid market in India is projected for substantial growth due to the increasing funding and foreign direct investment inflow.
A few global key market players are Aurobindo Pharma Limited; Assertio Therapeutics, Inc.; AbbVie Inc.; Actavis Plc.; Amneal Pharmaceuticals LLC; Boehringer Ingelheim International GmbH; Cadila Healthcare Limited; Fresenius Kabi; Mallinckrodt Pharmaceuticals; Endo International plc; Johnson & Johnson Corporation; Lupin Limited; Nesher Pharmaceuticals LLC; Purdue Pharma L.P.; Pfizer Inc.; Rhodes Pharmaceuticals L.P.; Sun Pharmaceutical Industries Limited; Trevena Inc.; Teva Pharmaceutical Industries Ltd.
Polaris Market Research has segmented the opioid market report on the basis of class, product, release type, application, and region:
Table 1 Global Opioid Market, by Class, 2020-2034 (USD billion)
Table 2 Global Opioid Market, by Product, 2020-2034 (USD billion)
Table 3 Global Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 4 Global Opioid Market, by Application, 2020-2034 (USD billion)
Table 5 North America: Opioid Market, by Class, 2020-2034 (USD billion)
Table 6 North America: Opioid Market, by Product, 2020-2034 (USD billion)
Table 7 North America: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 8 North America: Opioid Market, by Application, 2020-2034 (USD billion)
Table 9 U.S.: Opioid Market, by Class, 2020-2034 (USD billion)
Table 10 U.S.: Opioid Market, by Product, 2020-2034 (USD billion)
Table 11 U.S.: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 12 U.S.: Opioid Market, by Application, 2020-2034 (USD billion)
Table 13 Canada: Opioid Market, by Class, 2020-2034 (USD billion)
Table 14 Canada: Opioid Market, by Product, 2020-2034 (USD billion)
Table 15 Canada: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 16 Canada: Opioid Market, by Application, 2020-2034 (USD billion)
Table 17 Europe: Opioid Market, by Class, 2020-2034 (USD billion)
Table 18 Europe: Opioid Market, by Product, 2020-2034 (USD billion)
Table 19 Europe: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 20 Europe: Opioid Market, by Application, 2020-2034 (USD billion)
Table 21 UK: Opioid Market, by Class, 2020-2034 (USD billion)
Table 22 UK: Opioid Market, by Product, 2020-2034 (USD billion)
Table 23 UK: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 24 UK: Opioid Market, by Application, 2020-2034 (USD billion)
Table 25 France: Opioid Market, by Class, 2020-2034 (USD billion)
Table 26 France: Opioid Market, by Product, 2020-2034 (USD billion)
Table 27 France: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 28 France: Opioid Market, by Application, 2020-2034 (USD billion)
Table 29 Germany: Opioid Market, by Class, 2020-2034 (USD billion)
Table 30 Germany: Opioid Market, by Product, 2020-2034 (USD billion)
Table 31 Germany: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 32 Germany: Opioid Market, by Application, 2020-2034 (USD billion)
Table 33 Italy: Opioid Market, by Class, 2020-2034 (USD billion)
Table 34 Italy: Opioid Market, by Product, 2020-2034 (USD billion)
Table 35 Italy: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 36 Italy: Opioid Market, by Application, 2020-2034 (USD billion)
Table 37 Spain: Opioid Market, by Class, 2020-2034 (USD billion)
Table 38 Spain: Opioid Market, by Product, 2020-2034 (USD billion)
Table 39 Spain: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 40 Spain: Opioid Market, by Application, 2020-2034 (USD billion)
Table 41 Netherlands: Opioid Market, by Class, 2020-2034 (USD billion)
Table 42 Netherlands: Opioid Market, by Product, 2020-2034 (USD billion)
Table 43 Netherlands: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 44 Netherlands: Opioid Market, by Application, 2020-2034 (USD billion)
Table 45 Russia: Opioid Market, by Class, 2020-2034 (USD billion)
Table 46 Russia: Opioid Market, by Product, 2020-2034 (USD billion)
Table 47 Russia: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 48 Russia: Opioid Market, by Application, 2020-2034 (USD billion)
Table 49 Rest of Europe: Opioid Market, by Class, 2020-2034 (USD billion)
Table 50 Rest of Europe: Opioid Market, by Product, 2020-2034 (USD billion)
Table 51 Rest of Europe: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 52 Rest of Europe: Opioid Market, by Application, 2020-2034 (USD billion)
Table 53 Asia Pacific: Opioid Market, by Class, 2020-2034 (USD billion)
Table 54 Asia Pacific: Opioid Market, by Product, 2020-2034 (USD billion)
Table 55 Asia Pacific: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 56 Asia Pacific: Opioid Market, by Application, 2020-2034 (USD billion)
Table 57 China: Opioid Market, by Class, 2020-2034 (USD billion)
Table 58 China: Opioid Market, by Product, 2020-2034 (USD billion)
Table 59 China: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 60 China: Opioid Market, by Application, 2020-2034 (USD billion)
Table 61 India: Opioid Market, by Class, 2020-2034 (USD billion)
Table 62 India: Opioid Market, by Product, 2020-2034 (USD billion)
Table 63 India: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 64 India: Opioid Market, by Application, 2020-2034 (USD billion)
Table 65 Malaysia: Opioid Market, by Class, 2020-2034 (USD billion)
Table 66 Malaysia: Opioid Market, by Product, 2020-2034 (USD billion)
Table 67 Malaysia: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 68 Malaysia: Opioid Market, by Application, 2020-2034 (USD billion)
Table 69 Japan: Opioid Market, by Class, 2020-2034 (USD billion)
Table 70 Japan: Opioid Market, by Product, 2020-2034 (USD billion)
Table 71 Japan: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 72 Japan: Opioid Market, by Application, 2020-2034 (USD billion)
Table 73 Indonesia: Opioid Market, by Class, 2020-2034 (USD billion)
Table 74 Indonesia: Opioid Market, by Product, 2020-2034 (USD billion)
Table 75 Indonesia: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 76 Indonesia: Opioid Market, by Application, 2020-2034 (USD billion)
Table 77 South Korea: Opioid Market, by Class, 2020-2034 (USD billion)
Table 78 South Korea: Opioid Market, by Product, 2020-2034 (USD billion)
Table 79 South Korea: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 80 South Korea: Opioid Market, by Application, 2020-2034 (USD billion)
Table 81 Australia: Opioid Market, by Class, 2020-2034 (USD billion)
Table 82 Australia: Opioid Market, by Product, 2020-2034 (USD billion)
Table 83 Australia: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 84 Australia: Opioid Market, by Application, 2020-2034 (USD billion)
Table 85 Rest of Asia Pacific: Opioid Market, by Class, 2020-2034 (USD billion)
Table 86 Rest of Asia Pacific: Opioid Market, by Product, 2020-2034 (USD billion)
Table 87 Rest of Asia Pacific: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 88 Rest of Asia Pacific: Opioid Market, by Application, 2020-2034 (USD billion)
Table 89 Middle East & Africa: Opioid Market, by Class, 2020-2034 (USD billion)
Table 90 Middle East & Africa: Opioid Market, by Product, 2020-2034 (USD billion)
Table 91 Middle East & Africa: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 92 Middle East & Africa: Opioid Market, by Application, 2020-2034 (USD billion)
Table 93 Saudi Arabia: Opioid Market, by Class, 2020-2034 (USD billion)
Table 94 Saudi Arabia: Opioid Market, by Product, 2020-2034 (USD billion)
Table 95 Saudi Arabia: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 96 Saudi Arabia: Opioid Market, by Application, 2020-2034 (USD billion)
Table 97 UAE: Opioid Market, by Class, 2020-2034 (USD billion)
Table 98 UAE: Opioid Market, by Product, 2020-2034 (USD billion)
Table 99 UAE: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 100 UAE: Opioid Market, by Application, 2020-2034 (USD billion)
Table 101 Israel: Opioid Market, by Class, 2020-2034 (USD billion)
Table 102 Israel: Opioid Market, by Product, 2020-2034 (USD billion)
Table 103 Israel: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 104 Israel: Opioid Market, by Application, 2020-2034 (USD billion)
Table 105 South Africa: Opioid Market, by Class, 2020-2034 (USD billion)
Table 106 South Africa: Opioid Market, by Product, 2020-2034 (USD billion)
Table 107 South Africa: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 108 South Africa: Opioid Market, by Application, 2020-2034 (USD billion)
Table 109 Rest of Middle East & Africa: Opioid Market, by Class, 2020-2034 (USD billion)
Table 110 Rest of Middle East & Africa: Opioid Market, by Product, 2020-2034 (USD billion)
Table 111 Rest of Middle East & Africa: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 112 Rest of Middle East & Africa: Opioid Market, by Application, 2020-2034 (USD billion)
Table 113 Latin America: Opioid Market, by Class, 2020-2034 (USD billion)
Table 114 Latin America: Opioid Market, by Product, 2020-2034 (USD billion)
Table 115 Latin America: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 116 Latin America: Opioid Market, by Application, 2020-2034 (USD billion)
Table 117 Mexico: Opioid Market, by Class, 2020-2034 (USD billion)
Table 118 Mexico: Opioid Market, by Product, 2020-2034 (USD billion)
Table 119 Mexico: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 120 Mexico: Opioid Market, by Application, 2020-2034 (USD billion)
Table 121 Brazil: Opioid Market, by Class, 2020-2034 (USD billion)
Table 122 Brazil: Opioid Market, by Product, 2020-2034 (USD billion)
Table 123 Brazil: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 124 Brazil: Opioid Market, by Application, 2020-2034 (USD billion)
Table 125 Argentina: Opioid Market, by Class, 2020-2034 (USD billion)
Table 126 Argentina: Opioid Market, by Product, 2020-2034 (USD billion)
Table 127 Argentina: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 128 Argentina: Opioid Market, by Application, 2020-2034 (USD billion)
Table 129 Rest of Latin America: Opioid Market, by Class, 2020-2034 (USD billion)
Table 130 Rest of Latin America: Opioid Market, by Product, 2020-2034 (USD billion)
Table 131 Rest of Latin America: Opioid Market, by Release Type, 2020-2034 (USD billion)
Table 132 Rest of Latin America: Opioid Market, by Application, 2020-2034 (USD billion)
List of Figures:
Figure 1. Global Opioid Market, 2020-2034 (USD billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Class
Figure 7. Global Opioid Market, by Class, 2024 & 2034 (USD billion)
Figure 8. Market by Product
Figure 9. Global Opioid Market, by Product, 2024 & 2034 (USD billion)
Figure 10. Market by Release Type
Figure 11. Global Opioid Market, by Release Type, 2024 & 2034 (USD billion)
Figure 12. Market by Application
Figure 13. Global Opioid Market, by Application, 2024 & 2034 (USD billion)